Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial

Journal article

Andrew A Lover
MedRXiv, 2020

DOI: https://doi.org/10.1101/2020.03.22.20040949

View PDF

Cite

APA Click to copy
Lover, A. A. (2020). Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial. MedRXiv. https://doi.org/ https://doi.org/10.1101/2020.03.22.20040949

Chicago/Turabian Click to copy
Lover, Andrew A. “Quantifying Treatment Effects of Hydroxychloroquine and Azithromycin for COVID-19: a Secondary Analysis of an Open Label Non-Randomized Clinical Trial.” MedRXiv (2020).

MLA Click to copy
Lover, Andrew A. “Quantifying Treatment Effects of Hydroxychloroquine and Azithromycin for COVID-19: a Secondary Analysis of an Open Label Non-Randomized Clinical Trial.” MedRXiv, 2020, doi: https://doi.org/10.1101/2020.03.22.20040949.

BibTeX Click to copy

@article{lover2020a,
  title = {Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial},
  year = {2020},
  journal = {MedRXiv},
  doi = { https://doi.org/10.1101/2020.03.22.20040949},
  author = {Lover, Andrew A}
}